Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JULIE K CALDERWOOD

Allopathic & Osteopathic Physicians Ophthalmology Pediatric Ophthalmology and Strabismus Specialist

NPI
1104144609
CMS profile
565182
Location
HUNTSVILLE, AL

General Payments · PY2018–2024

$2,979.61

  • Reported across 81 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$290.84

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $290.84 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $260.08 15
Alexion Pharmaceuticals, Inc. $30.76 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $158.22 9
PY2019 $157.45 10
PY2020 $84.65 6
PY2021 $105.40 6
PY2022 $1,913.28 26
PY2023 $269.77 8
PY2024 $290.84 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $30.76 09/10/2024 Food and Beverage Undisputed 01/23/2026 1094042063 CMS
Amgen Inc. $19.43 01/22/2024 Food and Beverage Undisputed 01/23/2026 1111541305 CMS
Amgen Inc. $19.26 02/27/2024 Food and Beverage Undisputed 01/23/2026 1111541307 CMS
Amgen Inc. $14.68 04/10/2024 Food and Beverage Undisputed 01/23/2026 1111541311 CMS
Amgen Inc. $15.07 04/18/2024 Food and Beverage Undisputed 01/23/2026 1111541309 CMS
Amgen Inc. $18.19 05/07/2024 Food and Beverage Undisputed 01/23/2026 1111541313 CMS
Amgen Inc. $14.85 05/21/2024 Food and Beverage Undisputed 01/23/2026 1111541315 CMS
Amgen Inc. $7.13 07/17/2024 Food and Beverage Undisputed 01/23/2026 1111541317 CMS
Amgen Inc. $14.58 07/31/2024 Food and Beverage Undisputed 01/23/2026 1111541319 CMS
Amgen Inc. $17.19 08/21/2024 Food and Beverage Undisputed 01/23/2026 1111541321 CMS
Amgen Inc. $6.82 08/21/2024 Food and Beverage Undisputed 01/23/2026 1111541323 CMS
Amgen Inc. $22.73 09/24/2024 Food and Beverage Undisputed 01/23/2026 1111541327 CMS
Amgen Inc. $28.41 10/22/2024 Food and Beverage Undisputed 01/23/2026 1111541325 CMS
Amgen Inc. $19.87 10/22/2024 Food and Beverage Undisputed 01/23/2026 1111541329 CMS
Amgen Inc. $26.57 11/13/2024 Food and Beverage Undisputed 01/23/2026 1111541331 CMS
Amgen Inc. $15.30 12/04/2024 Food and Beverage Undisputed 01/23/2026 1111541333 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.